Breast reconstruction is a deeply personal issue, and patients should be able to...
The approval of Sarepta Therapeutics’ gene therapy, Elevidys, is an ecstatic mom...
The medical device industry is split on whether a proposed new Medicare reimburs...
The FDA on Thursday approved a gene therapy to treat people with hemophilia A, a...
Because they slow down digestion in early weeks, drugs like Ozempic and Mounjaro...
Can Novavax finally get it right? What's a "triple-G" drug? And is Novo Nordisk ...
Medical leaders reacted swiftly to the Supreme Court’s decision on affirmative a...
Carrie Harney, the vice president of government and regulatory Affairs at US Pha...
Genprex has announced that the FDA has granted fast-track designation for Reqors...
Pfizer has announced that the FDA has approved Ngenla (somatrogon-ghla), a paedi...
Cellusion shares Phase I/II clinical development plans for its bullous keratopat...
Research has shown that GLP-1RAs may have the potential to treat chronic metabol...
Experts warn caution around CRISPR gene editing technology on human embryos as i...
While Alvotech aims to file a new application, the FDA's rejection delays the dr...
AstraZeneca has announced impressive results for its STRIDE regimen, significant...
The FDA has announced that Lantidra, a cellular therapy for type 1 diabetes, has...
